Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s revision label changed from v3.5.3 to v3.5.4, signaling a minor update to the page. There is no evident modification to the study details, eligibility criteria, or results in the provided context.
    Difference
    0.1%
    Check dated 2026-05-15T04:17:40.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3 on the page. This reflects a minor deployment or content refresh to the study details page.
    Difference
    0.1%
    Check dated 2026-04-30T18:18:32.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:14:26.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:29:03.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study record now shows Completed status, the primary completion date, enrollment, and a new 2025 publication summarizing the results.
    Difference
    0.1%
    Check dated 2026-03-18T13:44:31.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 replaces v3.4.2 as the page framework version.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:17.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.